scholarly article | Q13442814 |
P50 | author | Peter Libby | Q22670611 |
Ralph Weissleder | Q7288259 | ||
Gregory Wojtkiewicz | Q47151952 | ||
Maarten Hulsmans | Q55363050 | ||
Gabriel Courties | Q58930790 | ||
Filip K Swirski | Q60190510 | ||
Matthias Nahrendorf | Q88985829 | ||
Yoshiko Iwamoto | Q93070371 | ||
Hendrik B Sager | Q114334709 | ||
Timo Heidt | Q114418294 | ||
Benoit Tricot | Q114418302 | ||
Matthew Sebas | Q114418308 | ||
P2093 | author name string | Yuan Sun | |
Partha Dutta | |||
P2860 | cites work | Interleukin-1 in the pathogenesis and treatment of inflammatory diseases | Q24606766 |
Identification of splenic reservoir monocytes and their deployment to inflammatory sites | Q24649151 | ||
Targeting interleukin-1 in heart disease | Q27009347 | ||
Macrophages in the pathogenesis of atherosclerosis | Q29617765 | ||
Immunological and inflammatory functions of the interleukin-1 family | Q29619669 | ||
The bone marrow at the crossroads of blood and immunity | Q33581299 | ||
Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity | Q33724394 | ||
Chronic variable stress activates hematopoietic stem cells | Q33864613 | ||
Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size | Q34028839 | ||
Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection | Q34112414 | ||
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure | Q34322056 | ||
Macrophages in atherosclerosis: a dynamic balance. | Q34368005 | ||
The interleukin-1 family: back to the future | Q34391415 | ||
Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines | Q34566222 | ||
Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis | Q35163433 | ||
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata | Q35251005 | ||
The inflammatory response in myocardial injury, repair, and remodelling. | Q35529656 | ||
Therapeutic siRNA silencing in inflammatory monocytes in mice | Q35539710 | ||
Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells | Q35589891 | ||
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis | Q35679591 | ||
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions | Q35687871 | ||
Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus | Q35776311 | ||
The bone marrow niche for haematopoietic stem cells | Q35887876 | ||
Myocardial infarction accelerates atherosclerosis. | Q36106602 | ||
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study). | Q36532549 | ||
Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. | Q36734858 | ||
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases | Q36816872 | ||
Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]. | Q36816882 | ||
Uncertainty in the niches that maintain haematopoietic stem cells | Q37103620 | ||
Monocyte and macrophage heterogeneity in the heart | Q37122225 | ||
IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. | Q37293969 | ||
The role of IL-1 in the pathogenesis of heart disease. | Q37460270 | ||
The IL-1 family: regulators of immunity | Q37676929 | ||
Monocyte and macrophage dynamics during atherogenesis | Q37890185 | ||
Mechanisms of acute coronary syndromes and their implications for therapy | Q38108628 | ||
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. | Q39982049 | ||
ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation | Q41789790 | ||
Macrophages are required for neonatal heart regeneration | Q41985583 | ||
IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia | Q42654069 | ||
Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity | Q42703006 | ||
IFNalpha activates dormant haematopoietic stem cells in vivo. | Q44358922 | ||
Neural stem and progenitor cells in nestin-GFP transgenic mice | Q44733594 | ||
Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse | Q44955371 | ||
Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). | Q44956453 | ||
Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. | Q53492981 | ||
Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6 | Q71707461 | ||
Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response | Q72692349 | ||
Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice | Q74171931 | ||
Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats | Q74477478 | ||
Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice | Q83630548 | ||
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) | Q85063666 | ||
IL-1 signaling in atherosclerosis: sibling rivalry | Q85947638 | ||
SnapShot: The hematopoietic stem cell niche | Q88219347 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
interleukins | Q194908 | ||
acute myocardial infarction | Q18558122 | ||
P304 | page(s) | 1880-1890 | |
P577 | publication date | 2015-09-10 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction | |
P478 | volume | 132 |
Q50560471 | Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins. |
Q46173512 | Antiarrhythmic effects of interleukin 1 inhibition after myocardial infarction |
Q37338935 | Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance. |
Q93012793 | Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition |
Q100446550 | Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction |
Q92943132 | Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X7R/NLRP3 inflammasome |
Q38812727 | Challenges and opportunities in treating inflammation associated with pulmonary hypertension |
Q89481046 | Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis |
Q34549707 | Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice |
Q50044861 | Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury. |
Q37734346 | Differential Regulation of Cardiac Function and Intracardiac Cytokines by Rapamycin in Healthy and Diabetic Rats |
Q90044758 | Diminished Reactive Hematopoiesis and Cardiac Inflammation in a Mouse Model of Recurrent Myocardial Infarction |
Q36773876 | Disordered haematopoiesis and athero-thrombosis. |
Q40959059 | E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction |
Q26770209 | From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection |
Q100381935 | Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction |
Q55332127 | Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients. |
Q92860891 | Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation |
Q50168083 | Immune mechanisms in heart failure. |
Q64054632 | Immunometabolism of Phagocytes and Relationships to Cardiac Repair |
Q57162899 | Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition |
Q38664204 | Inflammation - Cause or Consequence of Heart Failure or Both? |
Q36464263 | Influence of interleukin-1 beta gene polymorphisms on the risk of myocardial infarction and ischemic stroke at young age in vivo and in vitro |
Q98226408 | Innate Immune Receptors, Key Actors in Cardiovascular Diseases |
Q47599422 | Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond |
Q64882827 | Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure: Getting Closer and Closer. |
Q36654171 | Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum". |
Q97526755 | Macrophage Dysregulation and Impaired Skin Wound Healing in Diabetes |
Q63915886 | Macrophages and Cardiovascular Health |
Q38820074 | Macrophages in Vascular Inflammation: Origins and Functions |
Q93062616 | Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts |
Q55234249 | Mapping macrophage polarization over the myocardial infarction time continuum. |
Q37740369 | Monocytes and macrophages in cardiac injury and repair |
Q88985831 | Myeloid cell contributions to cardiovascular health and disease |
Q52619556 | Myocardial Infarction Remodeling that Progresses to Heart Failure: A Signaling Misunderstanding. |
Q90729117 | Natural lavender oil (Lavandula angustifolia) exerts cardioprotective effects against myocardial infarction by targeting inflammation and oxidative stress |
Q57176906 | New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types |
Q50027672 | Non-Invasive Immuno-Metabolic Cardiac Inflammation Imaging Using Hyperpolarized Magnetic Resonance. |
Q41728608 | Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure. |
Q37445494 | RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction. |
Q92465575 | Regulation of connexin 43 by interleukin 1β in adult rat cardiac fibroblasts and effects in an adult rat cardiac myocyte: fibroblast co-culture model |
Q50187351 | Resident and Monocyte-Derived Macrophages in Cardiovascular Disease. |
Q37603197 | Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology |
Q39363562 | Role of the immune system in cardiac tissue damage and repair following myocardial infarction |
Q55318421 | Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction. |
Q92613460 | Skin Wounding-Induced Monocyte Expansion in Mice Is Not Abrogated by IL-1 Receptor 1 Deficiency |
Q52730911 | Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. |
Q38875774 | The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. |
Q45069046 | The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology |
Q58592667 | The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4) |
Q45073088 | The NLRP3 inflammasome in acute myocardial infarction |
Q89908670 | The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction |
Q90208031 | The Quest for Antiinflammatory and Immunomodulatory Strategies in Heart Failure |
Q92652912 | The Role of Macrophages in the Infarcted Myocardium: Orchestrators of ECM Remodeling |
Q47696973 | The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes |
Q64065124 | Toward Regeneration of the Heart: Bioengineering Strategies for Immunomodulation |
Q28066351 | Towards an understanding of the painful total knee: what is the role of patient biology? |
Q91599400 | miR-499 released during myocardial infarction causes endothelial injury by targeting α7-nAchR |